“Vortioxetine improves gastrointestinal motility and reduces intestinal inflammation in a cuprizone-induced multiple sclerosis model in mice” (2026) Annals of Medical Research, 33(5), pp. 192–198. Available at: http://www.annalsmedres.org/index.php/aomr/article/view/4909 (Accessed: 1 June 2026).